Tanvex BioPharma (TPE:6541) Current Accrued Expense : NT$0.00 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Tanvex BioPharma Current Accrued Expense?

Tanvex BioPharma's Current Accrued Expense for the quarter that ended in Mar. 2025 was NT$0.00 Mil.

Tanvex BioPharma Current Accrued Expense Historical Data

The historical data trend for Tanvex BioPharma's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tanvex BioPharma Current Accrued Expense Chart

Tanvex BioPharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Accrued Expense

Get a 7-Day Free Trial

Tanvex BioPharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Current Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Tanvex BioPharma Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Tanvex BioPharma Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Tanvex BioPharma's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Tanvex BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tanvex BioPharma Inc (TPE:6541) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 376, Ren\'ai Road, Section 4, 13th Floor-1, Da\'an District, Taipei, TWN, 106

Website

https://www.tanvex.com

Tanvex BioPharma Inc is a biopharmaceutical company. It is engaged in the research, development, manufacture, and sale of biosimilar products and contract development and manufacturing of biological medicine. The company's products are used to cure diseases such as Neutropenia, Breast Cancer, Metastatic Colorectal Cancer, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the United States.

Tanvex BioPharma Headlines

No Headlines